Skip to content

Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta

Internal Iliac Artery Ligation Before Cesarean Hysterectomy in Morbidly Adherent Placenta: A Randomized Clinical Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03824873
Enrollment
40
Registered
2019-01-31
Start date
2017-03-01
Completion date
2020-07-02
Last updated
2020-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss

Keywords

Internal iliac artery, Internal iliac artery ligation, Placenta previa, Placenta accreta, cesarean hysterectomy

Brief summary

40 pregnant females at term diagnosed with morbidly adherent placenta and planned for elective cesarean section were recruited and randomized to 2 groups. Group A: Internal iliac ligation followed by cesarean hysterectomy. Group B: cesarean hysterectomy.

Interventions

Internal iliac artery ligation and cesarean hysterectomy

cesarean hysterectomy

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Placenta previa accreta * Previous 2 cesarean section * completed her family * Hemoglobin \> 11 gm/dl * Elective cesarean hysterectomy

Exclusion criteria

* Anemia ( Hemoglobin \< 11 gm/dl) * Not completed her family * BMI \> 35 Kg/m2 * Bleeding tendency * Emergengy cesarean section * Thrombophilia

Design outcomes

Primary

MeasureTime frame
Amount of blood lossintraoperative
Amount of Blood transfusion needed in mililiters24 hours

Secondary

MeasureTime frameDescription
change of hemoglobin24 hours
change of hematocrit24 hours
operative timeintraoperative
incidence of injury of important structures during operationintraoperativeincidence of injury of important structures during operation as urinary bladder, ureteric, intestinal or great vessels injury

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026